AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionInvestmark Advisory Group LLC
Latest Disclosed Ownership23,140 shares
Latest Disclosed Value $ 5,032,858
Investmark Advisory Group LLC reports 1.21% decrease in ownership of ABBV / AbbVie Inc.

On May 15, 2026 - Investmark Advisory Group LLC filed a 13F-HR form disclosing ownership of 23,140 shares of AbbVie Inc. (MX:ABBV) valued at $5,032,858 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 23,424 shares of AbbVie Inc.. This represents a change in shares of -1.21% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBVIE COM 00287Y109 23,140 -284 -1.21 5,033 -5.98 2.1539
2026-01-28 2025-12-31 13F ABBVIE COM 00287Y109 23,424 -773 -3.19 5,352 -4.46 2.2797
2025-10-23 2025-09-30 13F ABBVIE COM 00287Y109 24,197 -257 -1.05 5,603 23.42 2.4299
2025-08-14 2025-06-30 13F ABBVIE COM 00287Y109 24,454 -1,417 -5.48 4,539 -16.25 2.1269
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 25,871 -410 -1.56 5,421 16.06 2.6775
2025-02-18 2024-12-31 13F ABBVIE COM 00287Y109 26,281 189 0.72 4,670 -9.36 2.2904
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 26,092 347 1.35 5,153 16.69 2.5018
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 25,745 -287 -1.10 4,416 -6.86 2.3551
2024-05-17 2024-03-31 13F ABBVIE COM 00287Y109 26,032 -1,110 -4.09 4,740 12.70 2.5997
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 27,142 197 0.73 4,206 4.73 2.4669
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 26,945 230 0.86 4,016 11.59 2.7210
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 26,715 150 0.56 3,599 -14.98 2.4004
2023-05-16 2023-03-31 13F ABBVIE COM 00287Y109 26,565 433 1.66 4,234 0.24 3.1089
2023-01-24 2022-12-31 13F ABBVIE COM 00287Y109 26,132 583 2.28 4,223 23.19 3.1306
2022-11-14 2022-09-30 13F Abbvie COM 00287Y109 25,549 607 2.43 3,428 -10.26 3.0792
2022-07-15 2022-06-30 13F Abbvie COM 00287Y109 24,942 266 1.08 3,820 -4.50 3.7756
2022-05-03 2022-03-31 13F/A-1 Abbvie COM 00287Y109 24,676 456 1.88 4,000 21.99 4.1242
2022-05-03 2022-03-31 13F Abbvie COM 00287Y109 24,220 0 3,279 3.0659
2022-05-03 2021-12-31 13F Abbvie COM 00287Y109 24,220 24,220 3,279 3.0659
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.